Feasibility and efficacy of oral 5-FU in combination with pembrolizumab and cisplatin as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma: A prospective observational study.

Authors: Jason Chia-Hsun Hsieh, Pei-Hung Chang, Meng-Che Hsieh, Jia-Hong Chen, Ming-Yu Lien, Ching-Liang Ho, Hung-Ming Wang, Kun-Yun Yeh, Ching-Yun Hsieh

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18009

Source: Full article

---

Abstract

e18009